Showing results (61-70 of 2,396) with videos related to

Sort By:
Pageof 240
Breast Cancer (Tokyo, Japan)|February 17, 2017
Social impacts of the work loss in cancer survivorsHideko Yamauchi, Chizuko Nakagawa, Takashi Fukuda
Breast Cancer (Tokyo, Japan)|March 22, 2017
Fulvestrant plus targeted agents versus fulvestrant alone for treatment of hormone-receptor positive advanced breast cancer progressed on previous endocrine therapy: a meta-analysis of randomized controlled trialsWen-Zhao Lin, Qi-Ni Xu, Hong-Biao Wang, et al.
Breast Cancer (Tokyo, Japan)|February 4, 2021
Analysis of plasma HER2 copy number in cell-free DNA of breast cancer patients: a comparison with HER2 extracellular domain protein level in serumShi Qui, Takashi Takeshita, Aiko Sueta, et al.
Breast Cancer (Tokyo, Japan)|August 15, 2019
miR-638 represses the stem cell characteristics of breast cancer cells by targeting E2F2Qiu-Yan Lin, Jia-Qi Wang, Li-Li Wu, et al.
Breast Cancer (Tokyo, Japan)|August 8, 2019
Assessment of significant procedures in multigene molecular detection for breast cancer in clinical laboratories: from variant detection to targeted therapyRui Zhang, Peng Gao, Jiansheng Ding, et al.
Breast Cancer (Tokyo, Japan)|September 19, 2019
A network meta-analysis on the efficacy of HER2-targeted agents in combination with taxane-containing regimens for treatment of HER2-positive metastatic breast cancerBao-Jie Xie, Li-Na Zhu, Can Ma, et al.
Breast Cancer (Tokyo, Japan)|November 20, 2004
Optimal particle size of radiocolloid for sentinel node identification in breast cancer-electron microscopic study and clinical comparisonKazuhiko Sato, David Krag, Kuniyoshi Tamaki, et al.
Breast Cancer (Tokyo, Japan)|November 20, 2004
Sensitization of chemotherapy by anti-HERAkemi Kataoka, Mayumi Ishida, Shigeru Murakami, et al.
Breast Cancer (Tokyo, Japan)|November 20, 2004
Clinical experience of weekly paclitaxel-based treatment as preoperative chemotherapy for patients with primary breast cancerMasahiro Watatani, Kazuki Ueda, Koji Daito, et al.
Breast Cancer (Tokyo, Japan)|November 20, 2004
A phase II study of S-1 in patients with metastatic breast cancer--a Japanese trial by the S-1 Cooperative Study Group, Breast Cancer Working GroupToshiaki Saek, Shigemitsu Takashima, Muneaki Sano, et al.
Pageof 240